Clinical Trial Update: Vascular Impact of Omega-3 in Metabolic Syndrome [NA]

View source ↗

Summary

A clinical trial evaluating the vascular effects of omega-3 fatty acids in individuals with metabolic syndrome and essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Metabolic Syndrome

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Essential Hypertension, Metabolic Syndrome | NA | Status: COMPLETED